Entry and egress of varicella virus blocked by same anti-gH monoclonal antibody
- PMID: 8396811
- DOI: 10.1006/viro.1993.1543
Entry and egress of varicella virus blocked by same anti-gH monoclonal antibody
Abstract
Varicella virus is one of the most reclusive human herpesviruses. The virus is not released from infected cultured cells. Rather, infectivity is transferred by fusion of contiguous cells. To further investigate this process, infected cells were viewed by scanning electron microscopy. Thousands of viral particles were observed in elongated clusters overlying the virus-induced syncytia. When virus-infected cells were covered postinfection with medium supplemented with a monoclonal antibody to glycoprotein gpIII (gH homolog), syncytial formation was completely blocked and no progeny viral particles were observed on the surface of the monolayer. Removal of the antibody was followed by rapid progression of cytopathic effect. Addition of antibody to other viral proteins did not alter the infection. Thus, a monoclonal antibody to a single viral determinant on glycoprotein gpIII (gH) can prevent syncytial formation postinfection and block progression of infectivity. Since the same monoclonal antibody can inhibit entry, this study greatly expands the role of antibody in the modulation of herpesvirus infection.
Similar articles
-
Anti-glycoprotein H antibody impairs the pathogenicity of varicella-zoster virus in skin xenografts in the SCID mouse model.J Virol. 2010 Jan;84(1):141-52. doi: 10.1128/JVI.01338-09. J Virol. 2010. PMID: 19828615 Free PMC article.
-
Neutralization epitope of the varicella-zoster virus gH:gL glycoprotein complex.Virology. 1994 Mar;199(2):458-62. doi: 10.1006/viro.1994.1145. Virology. 1994. PMID: 7510086
-
A human monoclonal antibody against varicella-zoster virus glycoprotein III.J Gen Virol. 1991 Sep;72 ( Pt 9):2065-73. doi: 10.1099/0022-1317-72-9-2065. J Gen Virol. 1991. PMID: 1654371
-
Analysis of the binding of monoclonal and polyclonal antibodies to the glycoproteins of antigenic variants of human respiratory syncytial virus by surface plasmon resonance.J Immunol Methods. 2005 Feb;297(1-2):143-52. doi: 10.1016/j.jim.2004.12.017. J Immunol Methods. 2005. PMID: 15777938
-
Immunology of the varicella-zoster virus glycoproteins.J Infect Dis. 1988 May;157(5):877-81. doi: 10.1093/infdis/157.5.877. J Infect Dis. 1988. PMID: 2834465 Review. No abstract available.
Cited by
-
Anti-glycoprotein H antibody impairs the pathogenicity of varicella-zoster virus in skin xenografts in the SCID mouse model.J Virol. 2010 Jan;84(1):141-52. doi: 10.1128/JVI.01338-09. J Virol. 2010. PMID: 19828615 Free PMC article.
-
Postentry events are responsible for restriction of productive varicella-zoster virus infection in Chinese hamster ovary cells.J Virol. 2006 Nov;80(21):10325-34. doi: 10.1128/JVI.00939-06. J Virol. 2006. PMID: 17041213 Free PMC article.
-
Characterization of Varicella-Zoster virus glycoprotein K (open reading frame 5) and its role in virus growth.J Virol. 1999 May;73(5):4197-207. doi: 10.1128/JVI.73.5.4197-4207.1999. J Virol. 1999. PMID: 10196316 Free PMC article.
-
How B cells shape the immune response against Mycobacterium tuberculosis.Eur J Immunol. 2009 Mar;39(3):676-86. doi: 10.1002/eji.200839148. Eur J Immunol. 2009. PMID: 19283721 Free PMC article. Review.
-
Human anti-varicella-zoster virus (VZV) recombinant monoclonal antibody produced after Zostavax immunization recognizes the gH/gL complex and neutralizes VZV infection.J Virol. 2013 Jan;87(1):415-21. doi: 10.1128/JVI.02561-12. Epub 2012 Oct 17. J Virol. 2013. PMID: 23077312 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources